“Swiss firm Novartis’s radioligand therapy, which delivers radioactive isotopes directly to tumours, has completely cleared metastatic cancers in trial patients - an unprecedented result. And, US researchers found that blocking an immune protein (IL-23) makes HPV vaccines effective against existing tumours, raising hopes for therapeutic vaccines.”
Quote from Fixthenews newsletter
How Novartis got ahead on ‘incredible’ cancer breakthrough
Preventive HPV vaccines work. Now a new discovery could also help eliminate existing cancers too
You must log in or register to comment.